Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 9.7B | 7.8B | 8.1B |
Cost of revenue | 4.6B | 5.4B | 4.6B | 4.4B |
Gross profit | 3.1B | 4.3B | 3.2B | 3.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.6B | 3.1B | 2.3B | 2.5B |
Operating income | 188.0M | 837.0M | 566.0M | 867.0M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 148.0M | 159.2M | 204.6M | 252.2M |
Other income expense | — | — | — | — |
Pretax income | 217.1M | 749.3M | 414.5M | 679.5M |
Tax provision | 56.8M | 175.4M | 150.7M | 240.4M |
Net income | 160.3M | 573.9M | 263.8M | 439.1M |
Basic EPS | — | 4.8 | 2.2 | 3.7 |
Diluted EPS | — | 4.8 | 2.2 | 3.7 |
Basic average shares | — | 118.6M | 118.3M | 118.7M |
Diluted average shares | — | 118.6M | 118.3M | 118.7M |
EBITDA | 552.8M | 1.1B | 811.9M | 1.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |